Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren Once Daily vs Twice Daily in Essential Hypertension
NCT00654875Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of aliskiren in essential hypertension, sponsored by Novartis. Started Mar 2008; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00654875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654875.